Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recurrence × Carboplatin × Clear all

Phase

Phase 2 16 Phase 1/2 10 Phase 3 8 Phase 1 6 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 5 Urinary Bladder Neoplasms 4 Ovarian Neoplasms 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Fallopian Tube Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Thymic epithelial tumor 1 Thrombocythemia, Essential 1 Squamous NSCLC 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Retinoblastoma 1 Recurrence 1 Primary Myelofibrosis 1 Primary Malignant Neoplasm of Ovary 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Nonsquamous Non-small Cell Lung Cancer 1

Interventions

Temozolomide 3 Etoposide 3 pembrolizumab 2 Lomustine 2 Haloperidol 2 Gemcitabine 2 Cyclosporine 2 vocimagene amiretrorepvec 1 trofosfamide 1 ruxolitinib 1 regorafenib 1 peginterferon alfa-2b 1 osimertinib 1 interferon gamma-1b 1 interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1 imetelstat 1 glumetinib 1 etoposide phosphate 1 eculizumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carbon-11 acetate 1 auricularum 1 aldesleukin 1 Thiotepa 1 Sirolimus 1 Rituximab 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡